Skip to main content
SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD logo

SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD — Investor Relations & Filings

Ticker · 002737 ISIN · CNE100001WT7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,262 across all filing types
Latest filing 2021-07-06 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 002737

About SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD

https://www.kuihuayaoye.com

Sunflower Pharmaceutical Group Co., Ltd. focuses on the research, development, manufacturing, and distribution of proprietary Chinese medicines, chemical drugs, and health supplements. The organization is particularly noted for its specialization in pediatric medicine, marketed under the "Little Sunflower" brand, which includes treatments for respiratory and digestive ailments. Its extensive product portfolio also covers gynecological health and general internal medicine. The group operates several integrated production bases and research institutes, facilitating a comprehensive approach to drug formulation and quality control. By leveraging a robust supply chain and a wide-reaching distribution network, the company provides a diverse range of over-the-counter and prescription solutions aimed at improving family health and wellness.

Recent filings

Filing Released Lang Actions
第四届董事会第八次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of the resolutions passed at the fourth board of directors' eighth meeting of the company. It details the approval of a fund subscription using company funds, includes voting results, and mentions independent directors' opinions. The content focuses on board decisions and meeting resolutions rather than financial results, audit opinions, or regulatory filings. The document length is short (809 characters) and it is a meeting resolution announcement, which fits the category of Board/Management Information (MANG).
2021-07-06 Chinese
2020年年度权益分派实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2020 annual equity distribution (dividend payment) by the company 葵花药业集团股份有限公司. It details the dividend amount, the record date, the ex-dividend date, the shareholders entitled to the dividend, and the method of dividend distribution. It also references the approval of the dividend plan at the 2020 annual general meeting and confirms that the implementation is consistent with that plan. The document does not contain financial statements or detailed financial performance data, but rather focuses on the dividend distribution details and related shareholder information. This matches the definition of a Notice of Dividend Amount (DIV), which announces dividend amounts, payment dates, and details for shareholders. The document length is 2436 characters, which is relatively short and typical for a dividend announcement. Therefore, the correct classification is DIV with high confidence.
2021-07-05 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, the price range, compliance with regulations, and the timeline of the repurchase activities. It does not contain financial statements or earnings data but focuses on the company's buyback of its own shares. The document length is short (1391 characters) and it is not an announcement of a report publication but a direct update on share repurchase progress. Therefore, it fits the category of Transaction in Own Shares (POS).
2021-07-01 Chinese
关于回购公司股份的进展公告
Transaction in Own Shares Classification · 100% confidence The document is a progress announcement regarding the company's share repurchase plan. It details the number of shares repurchased, the price range, compliance with regulations, and other procedural information about the buyback. It does not contain financial statements or earnings data, nor is it a report or presentation. The content matches the description of a report on the company buying back its own shares (share repurchase/issuance). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is short and focused solely on the buyback progress, confirming it is not a full financial report or announcement of a report publication.
2021-06-02 Chinese
关于使用闲置自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement from a company regarding the progress of using idle funds for cash management, detailing specific investments in bank financial products, risk control measures, and the impact on the company. It includes tables of investment amounts, dates, and expected returns. The document is relatively short (2963 characters) and does not contain comprehensive financial statements or detailed financial performance data. It is an update on financing activities related to cash management rather than a full financial report or earnings release. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2021-05-20 Chinese
北京市天元律师事务所关于葵花药业集团股份有限公司2020年年度股东大会的法律意见
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion issued by a law firm regarding the 2020 Annual General Meeting (AGM) of shareholders of a company. It details the procedures of the AGM, the qualifications of attendees, the voting process, and the results of the votes on various proposals related to the company's 2020 annual reports and financial statements. The document is not the annual report itself but a legal opinion on the AGM and its voting results. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting outcomes of the AGM. The document length (6114 characters) and content confirm it is a detailed voting result announcement rather than a brief notice or a full annual report.
2021-05-18 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.